Erythema multiforme
MONDO:0006545Erythema multiforme (EM) refers to a group ofhypersensitivity disorders characterized by symmetric red, patchy lesions, primarily on the arms and legs. The cause is unknown, but EM frequently occurs in association with herpes simplex virus, suggesting an immunologic process initiated by the virus. In half of the cases, the triggering agents appear to be medications, including anticonvulsants, sulfonamides, nonsteroidal anti-inflammatory drugs, and other antibiotics. In addition, some cases appear to be associated with infectious organisms such as Mycoplasma pneumoniae and many viral agents. Erythema multiforme is the mildest of three skin disorders that are often discussed in relation to each other. It is generally the mildest of the three. More severe is Stevens-Johnson syndrome. The most severe of the three is toxic epidermal necrolysis (TEN).
Also known as: Dermatostomatitis, erythema multiforme type, EM, Herpes iris, erythema multiforme type, erythema multiforme bullosum, erythema polymorphe, erythema multiforme type, febrile mucocutaneous syndrome
8 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
Hope for chronic skin pain: drug shows promise in small trial
Disease control CompletedThis study tested a drug called apremilast (Otezla) in 6 people with a chronic, painful skin condition called erythema multiforme that did not get better with standard treatments. The goal was to see if the drug could reduce the number of flare-ups and pain over 6 months. The stu…
Phase: PHASE2 • Sponsor: Robert Micheletti • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
AI could cut skin specialist wait times, study hints
Knowledge-focused CompletedThis study tested an artificial intelligence algorithm designed to help primary care doctors decide whether a patient with a skin condition really needs to see a dermatologist. Researchers enrolled 200 adults with skin problems and had their doctors take photos of the affected ar…
Sponsor: AI Labs Group S.L • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC